Catalent
ISIN US1488061029
|WKN A112H2
Market cap (in EUR)
10,974.72 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
CATALENT, INC. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. The company's oral, injectable, and respiratory delivery technologies address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products.
Source: AfU Research GmbH
Source: AfU Research GmbH
Healthcare Healthcare Services Outsourced Development and Manufacturing Services United States
Financials
Key metrics
| Market capitalisation, EUR | 10,974.72 m |
| EPS, EUR | -2.09 |
| P/B ratio | 3.25 |
| P/E ratio | 201.50 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 4,050.96 m |
| Net income, EUR | -964.43 m |
| Profit margin | -23.81% |
What ETF is Catalent in?
There is 1 ETF which contains Catalent.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
